APA (7th ed.) Citation

SW, P., K, F., YC, C., YW, K., JY, F., CC, S., . . . JJ, Y. (2026). Soluble Programmed Death-1 as a Biomarker of Severity and Progression in Nodular-bronchiectatic Nontuberculous Mycobacterial Pulmonary Disease: A Multicountry Validation Cohort Study. Archivos de bronconeumologia. https://doi.org/10.1016/j.arbres.2026.06.006

Chicago Style (17th ed.) Citation

SW, Pan, Furuuchi K, Chen YC, Kuo YW, Feng JY, Shu CC, Morimoto K, and Yim JJ. "Soluble Programmed Death-1 as a Biomarker of Severity and Progression in Nodular-bronchiectatic Nontuberculous Mycobacterial Pulmonary Disease: A Multicountry Validation Cohort Study." Archivos De Bronconeumologia 2026. https://doi.org/10.1016/j.arbres.2026.06.006.

MLA (9th ed.) Citation

SW, Pan, et al. "Soluble Programmed Death-1 as a Biomarker of Severity and Progression in Nodular-bronchiectatic Nontuberculous Mycobacterial Pulmonary Disease: A Multicountry Validation Cohort Study." Archivos De Bronconeumologia, 2026, https://doi.org/10.1016/j.arbres.2026.06.006.